Brind.
  1. Major pharmaceutical companies face industry-wide pressure from patent cliffs and the need to streamline operations.

Moderna, Merck, and AbbVie are seeking new revenue streams to offset losses caused by patent expirations.

2 reports, 2 independent Updated Sep 6
Gone quiet
Reports
2
Developments
1
Repetition
50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Moderna, Merck, and AbbVie are seeking new revenue streams to offset losses caused by patent expirations.

Who's involved

What this event is mainly about
ModernaMerckAbbVie

Keep exploring

Part of

Major pharmaceutical companies face industry-wide pressure from patent cliffs and the need to streamline operations. All 1 developments

The entities involved

Coverage

Newest first; wire copies grouped